Merck & Co | 8-K: Merck Announces First-Quarter 2024 Financial Results
Apr 25 18:44
Merck & Co | DEFA14A: Others
Apr 12 04:16
Merck & Co | DEF 14A: Definitive information statements
Apr 12 04:12
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 20 04:36
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 20 04:32
Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024
Feb 21 05:20
Merck & Co | 8-K: Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Feb 1 19:41
Merck & Co | 8-K: The Board of Directors of the Company Elected Dalton E. Smart III to Serve as Senior Vice President Finance – Global Controller of the Company
Nov 29, 2023 05:51
Merck & Co | 8-K: Merck Announces Third-Quarter 2023 Financial Results
Oct 26, 2023 18:38
Merck & Co | 8-K: Merck Announces Second-Quarter 2023 Financial Results
Aug 1, 2023 18:46
Merck & Co | 8-K: Poll Results of Merck & Co Meeting
May 26, 2023 21:00
Merck & Co | 8-K: Merck & Co closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.050% Notes due 2028
May 18, 2023 04:31
Merck & Co | 8-K: Merck Announces First-Quarter 2023 Financial Results
Apr 27, 2023 18:43
Merck & Co | DEFA14A: Others
Apr 4, 2023 04:10
Merck & Co | DEF 14A: Definitive proxy statements
Apr 4, 2023 04:06
Merck & Co | 8-K: Merck & Co Announces Fourth-Quarter and Full-Year 2022 Financial Results
Feb 2, 2023 19:42
Merck & Co | 8-K: Merck Announces Third-Quarter 2022 Financial Results
Oct 27, 2022 18:38
Merck & Co | 8-K: Current report
Jul 28, 2022 18:36
Merck & Co | 8-K: Current report
May 27, 2022 04:06
Merck & Co | 8-K: Current report
Apr 28, 2022 18:35
No Data
No Data